CIDRAP newsletters options
The researchers were able to isolate infectious virus from 2 samples, including an air sample.
People lied mostly over a desire for normalcy and personal freedom.
A new global estimate of people who experienced long-COVID symptoms after having symptomatic COVID infection suggests that 6.2% reported one of three long-term symptom clusters, an international research group reported yesterday in JAMA.
Omicron was tied to a lower risk of maternal critical care (0.3% vs 1.8%) and preterm birth (1.8% vs 4.2%).
Of 219 patients, 216 (99%) reported sexual or close intimate contact in the 21 days before symptom onset.
A US study of almost 17,000 patients finds modest two-dose Pfizer COVID vaccine effectiveness (VE) against hospitalization and emergency department (ED) admission for Omicron BA.1 (the original Omicron variant) and the BA.2 subvariant, but three-dose VE was 79% and 71% for hospitalization, respectively, and 72% and 21% for ED visits.
A simulated client study in Ethiopia found a high rate of non-prescription antibiotic dispensing at community pharmacies, researchers reported today in the Journal of Antimicrobial Chemotherapy.
Teens reported low physical activity, poor quality of life, and high rates of anxiety and depression in 2020.
COVID activity continued to rise in many European countries last week, up 14% compared to the previous week, in people ages 65 and older, the European Centre for Disease Prevention and Control (ECDC) said today in a regular update.
In the United States, COVID indicators continue to fall, with the BA.5 Omicron variant still dominant, but newer subvariants are slowly making more of a mark.
The results of a randomized clinical trial in Slovenia suggest that a 7-day course of antibiotics for a rash caused by Lyme disease is noninferior to a 14-day course, researchers reported yesterday in The Lancet Infectious Diseases.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Children who had an underlying illness were at greatest risk for severe COVID-19 and death, but those who were vaccinated were fairly well protected, according to an observational study presented this week at the American Academy of Pediatrics (AAP) National Conference & Exhibition in Anaheim, California.
Protection from earlier pre Omicron infection was modest, but strong from earlier Omicron infection.
Disparities still persist in disease burden, as well as monkeypox vaccine reach.
In a phase 3 trial, cefepime/enmetazobactam was noninferior to piperacillin/tazobactam for treating complicated urinary tract infections.
The US Centers for Disease Control and Prevention (CDC) urged clinicians to consider Ebola and other viral hemorrhagic fever illness in the workup of people who have symptoms of the diseases and to immediately take a travel history with an eye toward identifying those who have been in parts of Uganda affected by the recent Ebola Sudan outbreak.
Funds will target drugs against gram-positive pathogens, vaccines for neonatal sepsis, and weapons against gonorrhea.
The survey also found that about a third feel confident about getting the flu shot and COVID booster at the same time.
People living in states with more complex guidelines were less likely to correctly indicate their eligibility.
So far 63 cases have been reported, including 29 deaths, and 10 healthcare workers have been infected.
